GlucoEasy has won the NWO Open Mind funding of € 50,000. The Open Mind grants are awarded by NWO to technologies with a surprisingly societal application.
Measure glucose, but comfortably
Diabetics should no longer have to measure their glucose levels by pricking blood. It can perhaps be a lot more comfortable, for example by measuring glucose levels in sweat. Dr. Elizabeth von Hauff, associated with the Vrije Universiteit Amsterdam, has won an Open Mind grant for that idea. Von Hauff proposes to combine two existing measurement techniques into a new, highly sensitive glucose measurer that can continuously measure without pricking. This new technique will not suffer from fluctuations in pH, temperature and composition – and that makes it suitable to measure glucose in something other than blood. GlucoEasy is one of the projects of Demonstrator Lab.
Open Mind financing
Five bold research proposals have received Open Mind funding of € 50,000 from NWO. The grants were awarded during Teknowlogy, NOW’s innovation congress. The winning proposals were appointed by a jury, led by Ionica Smeets. NWO awards five Open Mind grants of € 50,000 for socially relevant research outside the beaten track.
Amsterdam researchers have secured Biotech Booster funding for a total of six projects, that include a promising cancer treatment, a new diagnostic method for Alzheimer’s Disease, an implant helping blindness, lab innovation in biotechnology, and a nutritional intervention for mental health. The researchers will develop a solid business case for their innovations in the time […]
NewsPULSE Sport, a start-up from the Demonstrator Lab, has reached a significant milestone by winning the prestigious 14th Dutch Sports Innovation Award. The company’s flagship product, a cutting-edge athlete management system, integrates advanced software and artificial intelligence to revolutionize athlete health and performance monitoring. About the Innovation PULSE Sport’s athlete management system provides a holistic […]
NewsVU-AMS is on a mission to revolutionize how we understand and manage stress-related health issues. Now an official VU spin-off, there are big plans for clinical applications. Founder of VU AMS Martin Gevonden explains: “We offer researchers autonomic biomarkers that are valid, reliable and easy to use, without getting under the skin.” After thriving in […]
News